Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(27 sites)
United States
University of Southern California, Los Angeles, California East Carolina University, Greenville, North Carolina Czechia
Vseobecna Fakultni Nemocnice v Praze, Prague, Prague Fakultni Nemocnice Brno, Brno, South Moravian Germany
Onkologisches Zentrum Donauwörth Neudegger - Onkomedeor Onkologische Zentren, Donauwörth, Bavaria Universitätsklinikum Frankfurt, Frankfurt am Main, Hesse Italy
Azienda Ospedaliero - Universitaria Careggi, Florence, Florence Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara, Novara, Novara Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Trieste Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino, Torino, Turin AULSS 8 Berica - Ospedale San Bortolo Di Vicenza, Vicenza, Vicenza Romania
Coltea - Spital Clinic, Bucharest, București Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca, Cluj Spitalul Filantropia - Craiova, Craiova, Dolj Serbia
Univerzitetski Klinicki Centar Srbije, Belgrade Klinicko-Bolnicki Centar Zemun, Belgrade Spain
Complejo Asistencial Universitario de Burgos - Hospital Universitario de Burgos, Burgos, Burgos Instituto De Investigacion Biomedica De A Coruna - Virologia Clinica, A Coruña, La Coruña Complejo Hospitalario Ruber Juan Bravo, Madrid, Madrid Hospital General Universitario Gregorio Marañón, Madrid, Madrid Turkey (Türkiye)
Ankara Üniversitesi Tip Fakültesi - Cebeci Arastirma ve Uygulama Hastanesi, Ankara, Ankara Kocaeli Üniversitesi Arastirma ve Uygulama Hastanesi, Ankara, Ankara Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Yenimahalle, Ankara Trakya Üniversitesi Saglik Arastirma ve Uygulama Merkezi, Edirne, Edirne Ege Universitesi Tip Fakultesi, Izmir, İzmir VM Medical Park Mersin Hastanesi, Mersin, Mersin Sakarya Universitesi Egitim ve Arastirma Hastanesi, Adapazarı, Sakarya